We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · June 20, 2022

Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients With Hematological Malignancies

Blood Cancer Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

Blood Cancer Journal
Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
Blood Cancer J 2022 May 31;12(5)86, V Piechotta, SC Mellinghoff, C Hirsch, A Brinkmann, C Iannizzi, N Kreuzberger, A Adams, I Monsef, J Stemler, OA Cornely, PJ Bröckelmann, N Skoetz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading